Controversies in the treatment of high-risk prostate cancer-what is the optimal combination of hormonal therapy and radiotherapy: a review of literature-Reference-Cited by-同舟云学术

Controversies in the treatment of high-risk prostate cancer-what is the optimal combination of hormonal therapy and radiotherapy: a review of literature

Published:2009-12-16 Issue:7 Volume:70 Page:701-709
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Al-Mamgani Abrahim,Lebesque Joos V.,Heemsbergen Wilma D.,Tans Lisa,Kirkels Wim J,Levendag Peter C.,Incrocci Luca

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21102/fullpdf

Reference37 articles.

1. American Cancer Society Cancer Facts and Figures 2007 http://www.cancer.org/statistics/cff2000/ selectedcancers.html≠prostate 2008

2. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

3. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial;Zietman;JAMA,2005

4. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A combinedin vitroand molecular dynamics simulation studies unveil the molecular basis of the anticancer potential of piperine targeting AKT1 against prostate cancer;Journal of Biomolecular Structure and Dynamics;2023-06-05

2. Nanoparticles and prostate cancer;Nano Drug Delivery Strategies for the Treatment of Cancers;2021

3. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial;The Lancet Oncology;2019-02

4. Interaction between 3-Bromopyruvate and SC-514 in prostate cancer treatment;Journal of Cancer Prevention & Current Research;2018-11-12

5. An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer;Recent Patents on Nanotechnology;2018-06-13